CTHIn ForceLegislation
National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2022
//
© 2026 Zoe. All rights reserved.
Zoe is a legal information platform. Always consult the Federal Register of Legislation for authoritative text.
National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2022
Start here
Turn the raw legal text into a practical explanation grounded in National Health (Pharmaceuticals and Vaccines—Cost Recovery) Regulations 2022.
(1) The Secretary may, at any time, initiate a review of a reviewable decision (other than an earlier decision under subsection (2)).
Note: The review could be initiated by a delegate of the Secretary (see subsection 6(5) of the Act).
(2) The Secretary may: (a) affirm, vary or revoke the reviewable decision; and (b) if the Secretary revokes the reviewable decision—make any other decision the Secretary thinks appropriate.
Note: Notice must be given of a decision under this subsection (see subsection 72(1)).